Related Experiment Video
Updated: Apr 3, 2026

07:07
Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
6.6K
Integration of multi-microarray datasets to identify chronic obstructive pulmonary disease-related miRNAs
Lin Hua1,2, Weiying Zheng1,2, Hong Xia1,2
1School of Biomedical Engineering, Capital Medical University, Beijing, 100069, China.
Bio-Medical Materials and Engineering
|September 26, 2015
Summary
Chronic obstructive pulmonary disease (COPD) mechanisms are unclear. This study identifies three microRNAs (miRNAs) – miR-223, miR-132, and miR-199a-5p – as potential biomarkers for diagnosing COPD.
Area of Science:
- Pulmonary Medicine
- Genetics
- Biomarker Discovery
Background:
- Mechanisms of chronic obstructive pulmonary disease (COPD) are not fully understood.
- MicroRNAs (miRNAs) are key regulators of gene expression and potential biomarkers for disease.
- Inconsistent results from previous miRNA expression studies hinder COPD understanding.
Purpose of the Study:
- To identify reliable COPD-related microRNAs (miRNAs) using a robust analytical method.
- To validate the diagnostic potential of identified miRNAs in distinguishing COPD patients from controls.
Main Methods:
- Utilized multiple co-inertia analysis (MCIA) to integrate three independent COPD microarray datasets.
- Performed differential expression analysis to identify consistently altered miRNAs across datasets.
- Assessed the classification performance of identified miRNAs using pooled sensitivity and specificity.
Main Results:
- Identified miR-223, miR-132, and miR-199a-5p as significantly associated with COPD.
- These miRNAs showed consistent differential expression across the analyzed microarray datasets.
- The three miRNAs achieved a pooled sensitivity of 0.96 and specificity of 0.75 in classifying COPD patients.
Conclusions:
- miR-223, miR-132, and miR-199a-5p are strongly associated with COPD.
- These miRNAs demonstrate significant potential as diagnostic biomarkers for COPD.
- The findings provide a foundation for further research into miRNA-based COPD diagnostics.

